(3,4-二氟-苯基)-甲基-胺 | 138563-54-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: (3,4-二氟-苯基)-甲基-胺
• 中文别名: 3,4-二氟-N-甲基苯胺
• 英文名称: 3,4-difluoro-N-methylaniline
• 英文别名: (3,4-difluoro-phenyl)-methyl-amine
• CAS: 138563-54-9
• 化学式: C₇H₇F₂N
• mdl: MFCD11152726
• 分子量: 143.136
• InChiKey: SULGSLUIIZBEEN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (3,4-二氟-苯基)-甲基-胺 在 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 生成 N-(3,4-difluorophenyl)-N-methylthiocarbamoylacetic acid
  参考文献：
  名称：

  The First Synthesis of N-Alkyl-N-Arylthiocarbamoylacetates and Acetic Acids

  摘要：

  N-Alkyl-N-arylthiocarbamoylacetates, the key intermediates for the synthesis of novel antinephritic agents, have been prepared for the first time. Some of the esters were in turn hydrolyzed to the corresponding acids, An alternative, indirect synthetic route was also developed to prepare some unusual acids.

  DOI：

  10.1080/00397910008087354
• 作为产物：
  描述：

  3,4-二氟苯胺 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 15.0h， 生成 (3,4-二氟-苯基)-甲基-胺
  参考文献：
  名称：

  Synthesis and cytotoxicity studies of quinoline-3-carbonitrile derivatives

  摘要：

  A series of quinoline-3-carbonitrile derivatives were designed and synthesized. Their cytotoxicity in vitro against four cancer cell lines (A549, HT-29, MDA-MB-231 and SMMC-7721) were evaluated by standard MTT assay. The pharmacological results showed that most of the prepared compounds displayed excellent selective cytotoxicity toward SMMC-7721 cell line. Among them, compounds 7c, 7e, 11b, 11f and 11g were more active than Gefitinb against SMMC-7721 cell line. (C) 2010 Ping Gong. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.

  DOI：

  10.1016/j.cclet.2010.03.016

文献信息

• CHROMENONE DERIVATIVES
  申请人：BARLAAM Bernard Christophe

  公开号：US20110098271A1

  公开（公告）日：2011-04-28

  The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , n and R 9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

  这项发明涉及公式I的香豆素衍生物或其药用盐，其中R1、R2、R3、R4、R5、R6、R7、R8、n和R9中的每一个具有在描述中定义的任何含义；它们的制备方法，含有它们的药物组合物以及它们在制造用于治疗细胞增殖紊乱的药物的药物中的使用。
• BIS-AROMATIC COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION
  申请人：Pelcman Benjamin

  公开号：US20100286215A1

  公开（公告）日：2010-11-11

  There is provided compounds of formula (I): wherein Y, ring A, D 1 , D 2 , D 3 , L 1 , Y 1 , L 2 , Y 2 , L 3 and Y 3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of leukotriene C 4 synthase is desired and/or required, and particularly in the treatment of a respiratory disorder and/or inflammation.

  提供了具有以下式（I）的化合物：其中Y、环A、D1、D2、D3、L1、Y1、L2、Y2、L3和Y3的含义如描述中所示，并且其药学上可接受的盐，这些化合物在治疗需要或者期望抑制白三烯C4合酶的疾病中非常有用，特别是在治疗呼吸道疾病和/或炎症方面。
• [EN] BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES BICYCLIQUES ET LEUR UTILISATION EN TANT QUE MODULATEURS DE GPR119
  申请人：SCHERING CORP

  公开号：WO2009143049A1

  公开（公告）日：2009-11-26

  The present invention relates to Bicyclic Heterocycle Derivatives of formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR1 19 in a patient.

  本发明涉及公式（I）的双环杂环衍生物，包含双环杂环衍生物的组合物，以及使用双环杂环衍生物治疗或预防患者的肥胖、糖尿病、代谢紊乱、心血管疾病或与GPR119活性相关的疾病的方法。
• AZEPANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
  申请人：Novira Therapeutics, Inc.

  公开号：US20150225355A1

  公开（公告）日：2015-08-13

  Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.

  本文提供了一些用于治疗HBV感染的化合物，以及其药物组合物和抑制、抑制或预防受试者HBV感染的方法。
• [EN] CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY<br/>[FR] DÉRIVÉS DE CHROMÉNONE À ACTIVITÉ ANTITUMORALE
  申请人：ASTRAZENECA AB

  公开号：WO2011051704A1

  公开（公告）日：2011-05-05

  The invention concerns chromenone derivatives of Formula (I) or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.

  这项发明涉及公式（I）的香豆素衍生物或其药用盐，其中R1、R2、R3、R4、R5、R6、R7、R8、n和R9中的每一个具有在描述中先前定义的任何含义；它们的制备方法，含有它们的药物组合物以及它们在制造用于治疗细胞增殖紊乱的药物的药物中的使用。